Every trade that managers of Exactech Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Exactech Inc in twelve months, the latest record being from 16 February 2018.
The full history, which starts in 2016, counts no purchases against 89 sales.
In the same market, recent insider purchases at GameStop Corp. and Xenon Pharmaceuticals Inc. also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2016 · cache
25 of 209 declarations
Exactech Inc is a company listed on the XNAS market, specializing in the development and manufacturing of orthopedic medical devices. It focuses on solutions for joint replacement surgeries.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2016 | 257.6 m USD | 215,000 USD | 0.01 USD | 10-K |
| Dec 2015 | 241.8 m USD | 14.8 m USD | 1.04 USD | 10-K |
| Dec 2014 | 248.4 m USD | 16.5 m USD | 1.18 USD | 10-K |
| Dec 2013 | 237.1 m USD | 15.4 m USD | 1.12 USD | 10-K |
| Dec 2012 | 224.3 m USD | 12.7 m USD | 0.96 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.